Published in J Clin Invest on August 01, 1987
Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis. Gut (1994) 2.28
Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease. Gut (2000) 1.99
Colonic mucus and mucosal glycoproteins: the key to colitis and cancer? Gut (1989) 1.35
Colonic mucin synthesis is increased by sodium butyrate. Gut (1995) 1.19
South Asian and European colitics show characteristic differences in colonic mucus glycoprotein type and turnover. Gut (1995) 0.95
Ion exchange chromatography of purified colonic mucus glycoproteins in inflammatory bowel disease: absence of a selective subclass defect. Gut (1991) 0.95
Glycoprotein synthesis and secretion by cultured small intestinal mucosa in coeliac disease. Gut (1989) 0.93
Biochemical characterization of rat colonic mucins secreted in response to Entamoeba histolytica. Infect Immun (1992) 0.89
Selective reduction of intestinal trefoil factor in untreated coeliac disease. Clin Exp Immunol (2002) 0.89
A mucus-secreting human colonic cancer cell line. Purification and partial characterization of the secreted mucins. Biochem J (1989) 0.86
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Epithelial cell renewal in cultured rectal biopsies in ulcerative colitis. Gastroenterology (1973) 2.48
Rate and pattern of epithelial cell proliferation in ulcerative colitis. Gut (1981) 2.08
Glycoprotein composition of colonic mucosa. Specific alterations in ulcerative colitis. Gastroenterology (1984) 2.06
Oligosaccharide structures of human colonic mucin. J Biol Chem (1985) 2.06
Composition of human colonic mucin. Selective alteration in inflammatory bowel disease. J Clin Invest (1983) 2.03
Glycoprotein synthesis and secretion by mucosal biopsies of rabbit colon and human rectum. J Clin Invest (1974) 1.75
Crypt cell production rate in ulcerative proctocolitis: differential increments in remission and relapse. Gut (1985) 1.68
The structure and physiology of gastrointestinal mucus. Adv Exp Med Biol (1982) 1.59
The diagnostic value of mucosubstances in rectal biopsies from patients with ulcerative colitis and Crohn's disease. Gut (1970) 1.58
Oligosaccharide structures of isolated human colonic mucin species. J Biol Chem (1985) 1.54
Organ culture of human rectal mucosa. Gastroenterology (1973) 1.49
Mucin secretion in inflammatory bowel disease: correlation with disease activity and dysplasia. Gut (1982) 1.43
Regional distribution and alterations of lectin binding to colorectal mucin in mucosal biopsies from controls and subjects with inflammatory bowel diseases. J Clin Invest (1985) 1.42
Glycoprotein synthesis, transport, and secretion by epithelial cells of human rectal mucosa: normal and cystic fibrosis. Lab Invest (1977) 1.42
Kinetic studies of the epithelial cells of the rectal mucosa in normal subjects and patients with ulcerative colitis. Gut (1966) 1.35
A histochemical comparison of the O-acylated sialic acids of the epithelial mucins in ulcerative colitis, Crohn's disease, and normal controls. J Clin Pathol (1979) 1.25
Comparison of human colonic mucoprotein antigen from normal and neoplastic mucosa. Cancer Res (1978) 1.18
Human colonic goblet cells. Demonstration of distinct subpopulations defined by mucin-specific monoclonal antibodies. J Clin Invest (1986) 1.16
Regulation of intestinal goblet cell secretion. II. A survey of potential secretagogues. Am J Physiol (1982) 1.16
Clinical aspects of gastrointestinal mucus. Adv Exp Med Biol (1982) 1.13
Development of anti-human colonic mucin monoclonal antibodies. Characterization of multiple colonic mucin species. J Clin Invest (1986) 1.10
Regulation of intestinal goblet cell secretion. III. Isolated intestinal epithelium. Am J Physiol (1984) 1.10
In vitro model for the assessment of luminal factors on rectal mucosa. Gut (1983) 0.98
Regulation of intestinal goblet cell secretion. I. Role of parasympathetic stimulation. Am J Physiol (1982) 0.90
Regional differences in normal and cancer-associated glycoconjugates of the human colon. J Natl Cancer Inst (1985) 0.89
Synthesis and secretion of colonic glycoproteins: evidence for shedding in vivo of low molecular weight membrane components. Biochim Biophys Acta (1980) 0.85
Proceedings: Changes in human colonic mucus in ulcerative colitis. Gut (1975) 0.85
Colonic glycoprotein secretion and calmodulin-acceptor proteins in the reserpine-treated rat. Am J Physiol (1985) 0.80
Regulation of intestinal goblet cell secretion. IV. Electrical field stimulation in vitro. Am J Physiol (1984) 0.80
Proliferative and antigenic properties of rectal cells in patients with chronic ulcerative colitis. Cancer Res (1984) 0.79
Unravelling the pathogenesis of inflammatory bowel disease. Nature (2007) 18.52
Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N Engl J Med (1996) 6.79
Population genetic structure of variable drug response. Nat Genet (2001) 6.35
Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med (1999) 6.24
Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun (2000) 5.65
Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J Immunol (2000) 4.12
Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science (1996) 3.32
Involvement of the sympathetic nervous system in tetanus. Studies on 82 cases. Lancet (1968) 3.18
Interstitial deletion of (17)(p11.2p11.2) in nine patients. Am J Med Genet (1986) 3.12
Chromosomal imbalance in the Aniridia-Wilms' tumor association: 11p interstitial deletion. Pediatrics (1978) 3.04
Evaluation of a serologic marker, CA19-9, in the diagnosis of pancreatic cancer. Ann Intern Med (1989) 3.02
Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J Exp Med (2001) 3.02
Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function. Gastroenterology (2007) 2.99
Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study. Inflamm Bowel Dis (2001) 2.80
Radiologic determination of intravascular volume status using portable, digital chest radiography: a prospective investigation in 100 patients. Crit Care Med (2001) 2.78
Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway. J Clin Invest (1994) 2.51
Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7. Neuron (2001) 2.29
Molecular analysis of the Smith-Magenis syndrome: a possible contiguous-gene syndrome associated with del(17)(p11.2). Am J Hum Genet (1991) 2.26
Oral trefoil peptides protect against ethanol- and indomethacin-induced gastric injury in rats. Gastroenterology (1996) 2.17
N-terminal domains of the human telomerase catalytic subunit required for enzyme activity in vivo. Mol Cell Biol (2001) 2.16
Controlled trial of repeated halothane anaesthetics in patients with carcinoma of the uterine cervix treated with radium. Lancet (1975) 2.15
Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor beta. Gastroenterology (1993) 2.13
Glycoprotein composition of colonic mucosa. Specific alterations in ulcerative colitis. Gastroenterology (1984) 2.06
Oligosaccharide structures of human colonic mucin. J Biol Chem (1985) 2.06
Temperature regulation in survivors of accidental hypothermia of the elderly. Lancet (1967) 2.03
Composition of human colonic mucin. Selective alteration in inflammatory bowel disease. J Clin Invest (1983) 2.03
Going the distance--the case for true colorectal-cancer screening. N Engl J Med (2000) 2.02
Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease. Gastroenterology (1996) 2.01
Identification and characterization of rat intestinal trefoil factor: tissue- and cell-specific member of the trefoil protein family. Proc Natl Acad Sci U S A (1991) 2.01
Treatment of sympathetic overactivity in tetanus. Lancet (1969) 1.98
Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein. Gastroenterology (1995) 1.93
Differential expression of transforming growth factors alpha and beta in rat intestinal epithelial cells. J Clin Invest (1989) 1.91
Intestinal epithelial cells both express and respond to interleukin 15. Gastroenterology (1996) 1.88
A revision of the lissencephaly and Miller-Dieker syndrome critical regions in chromosome 17p13.3. Hum Mol Genet (1997) 1.84
The trefoil peptide family. Annu Rev Physiol (1996) 1.83
Fractalkine is an epithelial and endothelial cell-derived chemoattractant for intraepithelial lymphocytes in the small intestinal mucosa. J Immunol (2000) 1.79
Effects of growth factors on an intestinal epithelial cell line: transforming growth factor beta inhibits proliferation and stimulates differentiation. Biochem Biophys Res Commun (1987) 1.75
Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice. Gastroenterology (2000) 1.75
Unbalanced placental expression of imprinted genes in human intrauterine growth restriction. Placenta (2005) 1.73
Epithelial glycoprotein is a member of a family of epithelial cell surface antigens homologous to nidogen, a matrix adhesion protein. Proc Natl Acad Sci U S A (1990) 1.72
The mechanical properties and molecular dynamics of plant cell wall polysaccharides studied by Fourier-transform infrared spectroscopy. Plant Physiol (2000) 1.71
Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut (1995) 1.70
Adult human colonic subepithelial myofibroblasts express extracellular matrix proteins and cyclooxygenase-1 and -2. Am J Physiol (1997) 1.70
Novel mutations of MYO15A associated with profound deafness in consanguineous families and moderately severe hearing loss in a patient with Smith-Magenis syndrome. Hum Genet (2001) 1.66
Intestinal trefoil factor confers colonic epithelial resistance to apoptosis. Proc Natl Acad Sci U S A (2000) 1.66
Expression of vascular adhesion molecules in inflammatory bowel disease. Gastroenterology (1992) 1.62
Acute polyneuritis requiring artificial respiration. Q J Med (1968) 1.58
Point mutations and an intragenic deletion in LIS1, the lissencephaly causative gene in isolated lissencephaly sequence and Miller-Dieker syndrome. Hum Mol Genet (1997) 1.57
Physician specialty and variations in the cost of treating patients with acute upper gastrointestinal bleeding. Gastroenterology (1997) 1.56
Fibroblast growth factors modulate intestinal epithelial cell growth and migration. Gastroenterology (1994) 1.55
Oligosaccharide structures of isolated human colonic mucin species. J Biol Chem (1985) 1.54
Peroxynitrite-induced rat colitis--a new model of colonic inflammation. Gastroenterology (1993) 1.53
Laryngectomy in the management of severe dysphagia in non-malignant conditions. Lancet (1965) 1.53
Transforming growth factor beta regulation of migration in wounded rat intestinal epithelial monolayers. Gastroenterology (1993) 1.51
Mandrax poisoning: conservative management of 116 patients. Br Med J (1968) 1.50
The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes Immun (2007) 1.50
First observation of the decays B(0) → D(+)K(-)π(+)π(-) and B(-) → D(0)K(-)π(+)π(-). Phys Rev Lett (2012) 1.50
Paraneoplastic pemphigus, cicatricial conjunctivitis, and acanthosis nigricans with pachydermatoglyphy in a patient with bronchogenic squamous cell carcinoma. Ophthalmology (1992) 1.46
Migration of human intestinal lamina propria lymphocytes, macrophages and eosinophils following the loss of surface epithelial cells. Clin Exp Immunol (1997) 1.46
Human intestinal epithelial cells express functional cytokine receptors sharing the common gamma c chain of the interleukin 2 receptor. Proc Natl Acad Sci U S A (1995) 1.45
Stool antigen testing for the diagnosis and confirmation of eradication of Helicobacter pylori infection: a prospective blinded trial. Intern Med J (2005) 1.44
Normal human colonic subepithelial myofibroblasts enhance epithelial migration (restitution) via TGF-beta3. Am J Physiol (1999) 1.42
A paradoxical reduction in susceptibility to colonic injury upon targeted transgenic ablation of goblet cells. J Clin Invest (1999) 1.31
Signal transduction pathway of human fibroblast growth factor receptor 3. Identification of a novel 66-kDa phosphoprotein. J Biol Chem (1997) 1.31
Cardiovascular disturbances in severe tetanus due to overactivity of the sympathetic nervous system. Anaesthesia (1969) 1.30
Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents. Br J Cancer (2004) 1.29
Growth factors in inflammatory bowel disease. Inflamm Bowel Dis (1999) 1.29
The discussion of end-of-life medical care by primary care patients and physicians: a multicenter study using structured qualitative interviews. The EOL Study Group. J Gen Intern Med (1994) 1.28
Distinct pathways of cell migration and antiapoptotic response to epithelial injury: structure-function analysis of human intestinal trefoil factor. Mol Cell Biol (2000) 1.27
A partial GDNF depletion leads to earlier age-related deterioration of motor function and tyrosine hydroxylase expression in the substantia nigra. Exp Neurol (2006) 1.23
Human intestinal goblet cells in monolayer culture: characterization of a mucus-secreting subclone derived from the HT29 colon adenocarcinoma cell line. Gastroenterology (1988) 1.19
An increased risk of Crohn's disease in individuals who inherit the HLA class II DRB3*0301 allele. Proc Natl Acad Sci U S A (1996) 1.19
Galactosyltransferase activities in human sera: detection of a cancer-associated isoenzyme. Biochem Biophys Res Commun (1975) 1.19
Interleukin-2 receptor beta subunit-dependent and -independent regulation of intestinal epithelial tight junctions. J Biol Chem (2001) 1.19
Functional interleukin-2 receptors on intestinal epithelial cells. J Clin Invest (1993) 1.18
Observations during endobronchial anaesthesia. II. Oxygenation. Br J Anaesth (1974) 1.17
Pernicious anaemia and Campylobacter like organisms; is the gastric antrum resistant to colonisation? Gut (1989) 1.17
Decreased elastin deposition and high proliferation of fibroblasts from Costello syndrome are related to functional deficiency in the 67-kD elastin-binding protein. Am J Hum Genet (2000) 1.16
Human colonic goblet cells. Demonstration of distinct subpopulations defined by mucin-specific monoclonal antibodies. J Clin Invest (1986) 1.16
Acute and late toxicity of patients with inflammatory bowel disease undergoing irradiation for abdominal and pelvic neoplasms. Int J Radiat Oncol Biol Phys (2000) 1.14
Down-regulation of Leishmania donovani trypanothione reductase by heterologous expression of a trans-dominant mutant homologue: effect on parasite intracellular survival. Proc Natl Acad Sci U S A (1998) 1.14
Hepatocyte growth factor/scatter factor modulates intestinal epithelial cell proliferation and migration. Biochem Biophys Res Commun (1994) 1.14
Analysis of parent of origin specific DNA methylation at SNRPN and PW71 in tissues: implication for prenatal diagnosis. J Med Genet (1996) 1.13
Intestinal trefoil factor induces inactivation of extracellular signal-regulated protein kinase in intestinal epithelial cells. Proc Natl Acad Sci U S A (1998) 1.13
Paradoxical roles of different nitric oxide synthase isoforms in colonic injury. Am J Physiol Gastrointest Liver Physiol (2004) 1.13
Regulation of transforming growth factor expression in rat intestinal epithelial cell lines. J Clin Invest (1991) 1.12
Swine as models in experimental surgery. J Invest Surg (1988) 1.12
Physical exercise in patients with severe kidney disease. Nephron Clin Pract (2010) 1.12
Cell-cycle and developmental regulation of TbRAB31 localisation, a GTP-locked Rab protein from Trypanosoma brucei. Mol Biochem Parasitol (2000) 1.12
Characterization of spontaneous colitis in cotton-top tamarins (Saguinus oedipus) and its response to sulfasalazine. Gastroenterology (1985) 1.11
The trefoil gene family are coordinately expressed immediate-early genes: EGF receptor- and MAP kinase-dependent interregulation. J Clin Invest (1999) 1.11
Intestinal fibroblasts regulate intestinal epithelial cell proliferation via hepatocyte growth factor. Am J Physiol (1998) 1.11
Characterization of human and rat intestinal trefoil factor produced in yeast. Biochemistry (1995) 1.11
Galactosyltransferase and concanavalin A agglutination of cells. Proc Natl Acad Sci U S A (1974) 1.11
Development of anti-human colonic mucin monoclonal antibodies. Characterization of multiple colonic mucin species. J Clin Invest (1986) 1.10
Submental intubation: an alternative to short-term tracheostomy. Anaesth Intensive Care (2000) 1.10
Increased chromosomal aberrations in first metaphases of cells isolated from the kidneys of aged mice. Isr J Med Sci (1985) 1.10
Rapid mitogen-activated protein kinase activation by transforming growth factor alpha in wounded rat intestinal epithelial cells. Gastroenterology (1998) 1.10
New life in a sleeper: thalidomide and Crohn's disease. Gastroenterology (1999) 1.10